跳至主要内容
临床试验/IRCT201212178698N4
IRCT201212178698N4已完成未知

Impact of L-carnitine on biomarkers of platelet activation in patients undergoing elective Percutaneous Coronary Intervention(PCI)

Tehran University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 90 years(—)
性别
All

入选标准

  • Patients with ischemic heart disease that have more than 50 percent occlusion in angiography findings and candidates for elective Pecrcutaneous Coronary Intevention.Exclusion criteria: cardiogenic shock;ST Elevation Myocardial Infarction;pregnant and lactating womens;patients under 18 years;immunologic or hematologic disorders;current infection;chronic kidney disease;serum creatinine above 2.5 mg/dl;hypothyroidism;epilepsy or convulsion;chronic liver disease;cancer

排除标准

  • 未提供

研究者

相似试验

已完成
3 期
Effect of L-carnitine inpatients with traumatic brain injuryTraumatic Brain Injury.Cerebral oedema traumatic (S06.1)
IRCT201410312582N9Research deputy of Tabriz University of Medical Sciences40
招募中
3 期
Effect of L-carnitine in Ischemic StrokeIschemic stroke.Cerebral infarction
IRCT20221206056734N1Ahvaz University of Medical Sciences82
招募中
不适用
Short-chain carnitines as potential biomarkers in depressed adolescents and their associations with aberrant (neuro)immunological and endocrinological parametersF32F33Depressive episodeRecurrent depressive disorder
DRKS00030637ehrstuhl für Kinder- und Jugendpsychiatrie und -psychotherapie der Universität Regensburg am Bezirksklinikum Regensburg (medbo)70
招募中
3 期
Effect of l-carnitine supplementation on inflammation, blood glucose and lipids in hemodialysis childreCondition 1: Chronic kidney disease, stage 5. Condition 2: dialysis complications. Condition 3: Dialysis-induced inflammation. Condition 4: Hyperlipidemia. Condition 5: hyperglycemia. Condition 6: carnitine deficiency. Condition 7: Disorder of fatty-acid metabolism.Chronic kidney disease, stage 5Kidney dialysis as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedureInfection and inflammatory reaction due to other internal prosthetic devices, implants and graftsHyperlipidemia, unspecifiedHyperglycemia, unspecifiedOther secondary carnitine deficiencyDisorder of fatty-acid metabolism, unspecifiedN18.5Y84.1T85.7E78.5R73.9E71.448E71.30
IRCT20170202032367N2Tehran University of Medical Sciences30
已完成
不适用
Evaluating the effect of L-carnitine on the prevention of postoperative atrial fibrillation and acute kidney injury (AKI) following coronery artery bypass grafting (CABG) surgery.ischemic heart disease.Atherosclerotic heart disease
IRCT201301028698N7Tehran university of medical sciences100
Impact of l-carnitine in percutaneous coronary... | 临床试验